Ozempic is technically a diabetes drug, but its often prescribed off-label for weight loss
doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach
doi: 10.1007/s00592-012-0381-6 40 SidneyJVelaJLFriedrichDKollaRvon HerrathMWesleyJDet al
The FDA ended the shortage February 21, 2025, and clarified on April 1, 2026 that B12 add-ons alone do not automatically qualify a script
Skin is composed of three main layers, the hypodermis, the dermis and the epidermis